Sunshine Bio Investments World Launches Funding Initiatives in Multi-Billion Dollar North American Markets Serving Stem Cell Research, Genomics, Proteonomics, Nanotechnologies, Mass Spectrometers, SNPs, PCRs and RFID

MIAMI, FL--(Marketwire - November 19, 2008) - Sunshine Bio Investments World, a privately held Canadian company (http://www.sunshinebioworld.com), has established U.S. headquarters in Miami and initiated venture funding for a variety of biotech, pharmaceutical and medical device companies active in the multi-billion dollar North American biotech environment.